Tags Biotechnology

Wed 22 Oct 2025

Sapian leads to in vivo results in liposarcoma

Kantify reports a preclinical proof-of-concept program in soft tissue sarcoma with a focus on liposarcoma

Thu 12 Dec 2024

Prostate cancer drug discovery: promising advance

A collaboration between Kantify and Johns Hopkins School of Medicine leads to initial, promising pre-clinical results on metastatic prostate cancer

Tue 30 Jul 2024

The Secret Life of Sildenafil (Viagra) revealed by AI

White Paper: Sapian AI unveils potential novel biological mechanisms of a wonder drug

Thu 11 Jul 2024

Recap of Rexpo 2024 on AI and Repurposing

Kantify's work on AI for target and drug prediction for rare diseases highlighted at Rexpo2024

Thu 17 Aug 2023

AI and Drug Repurposing: Farewell, serendipity?

Our pledge to make therapies available for patients, faster, and why Artificial Intelligence is the key for small molecule repurposing

Fri 29 Apr 2022

ADMET prediction with Artificial Intelligence : Publication

Peer reviewed publication "Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination"

Mon 14 Mar 2022

Artificial Intelligence for Targeted Protein Degradation

Discover how Kantify’s AI -based drug discovery tool, Sapian, accelerates the discovery of promising Targeted Protein Degraders (PROTAC, DUBTAC, LYTAC,...),

Thu 27 May 2021

Key AI Techniques in small molecule screening

Discover the key Artificial Intelligence techniques used for small molecule screening

Thu 11 Sep 2025

Kantify at the CONDOR Symposium on Sarcoma

Kantify will participate at the annual event of the CONDOR Symposium which will focus on Microenvironment And Immunotherapy Of Sarcomas

Wed 11 Jun 2025

Kantify Contributes to the EU Biotech Act Consultation

Kantify has submitted its contribution to the European Commission’s consultation on the upcoming “EU Biotech Act”—a critical initiative to advance biotechnology

Wed 04 Jun 2025

AI & drug discovery: presentation at Laminopathy Conference

Kantify presents how AI helps with rare neuromuscular disorders drug discovery at the 5th International Laminopathy Conference

Tue 06 May 2025

AI and Repurposing: Kantify's COO at iDR25

Nicolas Maignan to deliver a presentation about AI for repurposing at the International Drug Repurposing Conference 2025

Tue 19 Nov 2024

AI for plants based drug discovery: Kantify lecture at IBMCP

How can AI accelerate target discovery and small molecule discovery in plants? First lecture at IBMCP

Thu 22 Aug 2024

DREAMS: when AI finds drugs for rare diseases

Discover on the DREAMS project website how Kantify contributes to the discovery of therapeutic targets and treatments for 5 rare neuromuscular disorders

Tue 02 Apr 2024

Kantify reveals promising results in sarcoma at ESMO

Kantify Unveiled Promising Results in Liposarcoma Drug Discovery thanks to AI at ESMO Sarcoma and Rare Cancer Congress 2024

Tue 19 Mar 2024

Nicolas Maignan appointed Chief Operating Officer of Kantify

Announcement: Nicolas Maignan is officially appointed COO of Kantify

Thu 14 Mar 2024

AI for Healthcare panel at the Pharma.be General Assembly

Kantify was invited at the pharma.be special panel on AI for Healthcare

Mon 11 Dec 2023

Kantify at Belgium's Biopharmaceutical Excellence Conference

Kantify shared some of its groundbreaking work at the Conference on the Belgian biopharmaceutical sector organized by the Federal Ministry of Foreign Affairs

Thu 07 Dec 2023

Appointment of Dr Eckhard von Keutz as Scientific Advisor

Kantify appoints Dr von Keutz, former Vice-President at Bayer Pharmaceuticals, as Scientific Advisor

Thu 15 Jun 2023

Presentation at Cafes de L'Innovation

Kantify is invited to present its work on AI for target identification and small molecule prediction at Institut Bordet

Tue 06 Jun 2023

Kantify Nominated as Early Startup to Watch by Sifted

We are featured in Sifted's report "AI-Driven Drug Discovery 2.0" Market Report

Fri 03 Mar 2023

Upcoming talk: in silico drug discovery and animal testing

Kantify will present at the upcoming study "Animals and Alternatives: The Way Forward"

Tue 28 Feb 2023

When AI meets Stem Cells: spotlight on our work with I-Stem

Kantify and I-Stem work together for faster rare disease drug discovery

Mon 06 Feb 2023

Special edition on Artificial Intelligence in La Libre Eco

Kantify in the special edition of La Libre Eco on Artificial Intelligence

Sun 05 Feb 2023

Kantify' CEO interview on TV LN24

Kantify's CEO was invited as "CEO of the week" by Bruno Wattenbergh on LN24

Thu 27 Oct 2022

Belgian AI Strategy: Kantify joins State Secretary

State Secretary Mathieu Michel invited us to illustrate the power of AI in Health at UCB for the launch event of the Belgian AI plan

Mon 17 Oct 2022

Kantify & Mcule harness data to accelerate drug discovery

Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction

Tue 09 Aug 2022

Kantify in BX1 show on startups and Artificial Intelligence

Kantify was invited to the special edition of BX-1's Startup Story on Start-Ups and Artificial Intelligence

Mon 02 May 2022

Register to our webinar : Targeted Protein Degraders and AI

Discover how Artificial Intelligence can be used in the discovery and design of Targeted Protein Degraders.

Wed 27 Apr 2022

New discovery with I-Stem (Press Release)

Announcement : Kantify And I-Stem use Artificial Intelligence (AI) and Stem Cells to Discover A Promising Therapy Against A Rare Disease

Wed 13 Apr 2022

Abstract selected for Knowledge For Growth

The Abstract presents how AI can be used to accelerate and derisk lead optimization by predicting ADMET properties and off-target binding scores

Mon 28 Mar 2022

Kantify at the annual event of Brussels' Healthtech cluster

Kantify is speaking at the annual event of the Brussels cluster of healthtech companies

Tue 22 Mar 2022

Unveiling Sapian, Kantify’s AI drug discovery technology

Discover the new AI technology that accelerates small molecule and targeted protein degradation discovery

Thu 30 Sep 2021

European Biotech Week: webinar on AI for Drug Discovery

Kantify hosted its first webinar titled Artificial Intelligence for Drug Discovery and Development, as a part of the European Biotechnology Week 2021

Wed 01 Sep 2021

Kantify at the European Biotech Week: AI for Drug Discovery

Kantify is hosting a virtual event during European Biotech Week titled: Artificial Intelligence in drug discovery and development

Thu 22 Jul 2021

Kantify joins the European Biotechnology Network

Kantify has joined the European Biotechnology Network dedicated to biotechnology and life sciences

Mon 10 May 2021

Kantify joins Data-driven Advanced Therapeutics Accelerator

Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst

Wed 14 Apr 2021

The CEO of Kantify interviews with DataNews

The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry

Wed 24 Mar 2021

European Commission Report on AI Uptake in Healthcare

The European Commission publishes a report to monitor the development, uptake and impact of Artificial Intelligence for healthcare.

Tue 16 Mar 2021

Kantify at the Belgian AI Week 2021

Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.